BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 12, 2007
View Archived Issues
Novel treatment options for cancer covered in recent patent literature
Read More
Snapshots in dermatology: The 16th EADV congress
Read More
Recent NeuroSearch and Memory patents describe novel antidepressants and antipsychotic agents
Read More
Soluble trimeric TRAIL shows promise for brain tumors
Read More
Long-term remission seen with MMX mesalamine in ulcerative colitis
Read More
Survivin-2B peptide vaccine evaluated in phase I urothelial cancer study
Read More
Recent Biogen patent discloses novel therapeutic agents for fibrosis and related disorders
Read More
Fast track designation for CellCept in treatment of lupus nephritis
Read More
Enrollment open in phase III study of Labopharm's once-daily trazodone
Read More
Phase I study begins for AIR parathyroid hormone
Read More
BioLineRx files to begin European pilot study of BL-1040
Read More
Series B financing to support phase I testing of PNP's cancer technology
Read More
New phase II trial studies Surfaxin for pediatric acute respiratory failure
Read More
Viread noninferior to Hepsera in HBeAg-negative/anti-HBe positive subjects
Read More
Nebido maintains clinically therapeutic testosterone levels in hypogonadal men
Read More
MK-0974 significantly improves migraine pain relief two hours postdosing
Read More
Albuferon shows comparable efficacy to Pegasys with better quality of life
Read More
Zonisamide SR shows improved tolerability over zonisamide IR
Read More
FDA and Nuvo discuss Pennsaid approvable letter
Read More
BioMS synthetic peptide enters U.S. phase III trial for multiple sclerosis
Read More
Fast track designation for tamibarotene in acute promyelocytic leukemia
Read More
Japanese orphan drug designation for Naglazyme
Read More
Priority review for Erbitux sBLA in metastatic colorectal cancer
Read More
Celecox launched in Japan
Read More
Japanese launch for imidafenacin for overactive bladder
Read More
Alvesco launched in Japan for bronchial asthma
Read More
Tracleer approved in E.U. to reduce digital ulcers in systemic sclerosis patients
Read More
KOS-1584: Phase I to continue with a 3-hour infusion regimen only
Read More
VX-001 elicits immune response, prolongs TTP and overall survival in NSCLC patients
Read More
Dosing schedule chosen for future trials of R-1507
Read More
Phase I/II trial of SPC-2996 shows benefits in advanced CLL
Read More